We certainly are Cru, and the elevator is on it's way up as we are now on the 1st floor. BLA will take us to the second floor, the third floor will be attained with Dr. Bruce P's. publication. For the fourth floor, we will need to see the outcome of Leronlimab's severe critical Covid-19 trial to continue to show efficacy and great results on reducing further patients from the " cytokine storms where the news is published all over the world as being one of the very few drugs to help bring the test patients back from the edge of doom.
Now, for us to get to the fifth floor, that will either be approval for Covid-19 against the Corona Virus or the FDA stops the trials and grants us stage 4 approval for the sickest of all patients as I see the virus not going away too soon and this agency will have to give us the nod to continue and the trial continues through the process.
The next floor may take a bit longer than we'd like but it should be the approval for Leronlimab for the combo HIV and a provisional grant to approval for HIV mono to get the ball rolling for revenue.
After we hit the sixth floor, it won't matter as all this time has passed, our cancer trials, which I think IMO, will have progressed to an extent that the FDA will have no other option after all the success to date, will see the many possible indications that Leronlimab can help with. I didn't say cure but I did say can definitely help improve the quality of life that these patients go through.
After all that, your guesses are as good as my guesses for other immuno-diseases not limited to influenza's, pneumonia etc.
Next floor anyone, all aboard - GLTA and Cru
HCIT
Now, for us to get to the fifth floor, that will either be approval for Covid-19 against the Corona Virus or the FDA stops the trials and grants us stage 4 approval for the sickest of all patients as I see the virus not going away too soon and this agency will have to give us the nod to continue and the trial continues through the process.
The next floor may take a bit longer than we'd like but it should be the approval for Leronlimab for the combo HIV and a provisional grant to approval for HIV mono to get the ball rolling for revenue.
After we hit the sixth floor, it won't matter as all this time has passed, our cancer trials, which I think IMO, will have progressed to an extent that the FDA will have no other option after all the success to date, will see the many possible indications that Leronlimab can help with. I didn't say cure but I did say can definitely help improve the quality of life that these patients go through.
After all that, your guesses are as good as my guesses for other immuno-diseases not limited to influenza's, pneumonia etc.
Next floor anyone, all aboard - GLTA and Cru
HCIT
3
